ATE206755T1 - Verwendungen einer proteinkinase von ton und neurofilament pk40 - Google Patents

Verwendungen einer proteinkinase von ton und neurofilament pk40

Info

Publication number
ATE206755T1
ATE206755T1 AT92915162T AT92915162T ATE206755T1 AT E206755 T1 ATE206755 T1 AT E206755T1 AT 92915162 T AT92915162 T AT 92915162T AT 92915162 T AT92915162 T AT 92915162T AT E206755 T1 ATE206755 T1 AT E206755T1
Authority
AT
Austria
Prior art keywords
kinases
neurofilament
clay
protein kinase
relating
Prior art date
Application number
AT92915162T
Other languages
English (en)
Inventor
Vernon M Ingram
Hanno M Roder
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE206755T1 publication Critical patent/ATE206755T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92915162T 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40 ATE206755T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74288091A 1991-08-09 1991-08-09
PCT/US1992/005825 WO1993003148A2 (en) 1991-08-09 1992-07-10 Tau/neurofilament protein kinases pk40 and pk36

Publications (1)

Publication Number Publication Date
ATE206755T1 true ATE206755T1 (de) 2001-10-15

Family

ID=24986618

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00104460T ATE262584T1 (de) 1991-08-09 1992-07-10 Verwendung eines inhibitors von tau/neurofilament-proteinkinase pk40
AT92915162T ATE206755T1 (de) 1991-08-09 1992-07-10 Verwendungen einer proteinkinase von ton und neurofilament pk40

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00104460T ATE262584T1 (de) 1991-08-09 1992-07-10 Verwendung eines inhibitors von tau/neurofilament-proteinkinase pk40

Country Status (9)

Country Link
EP (2) EP0667898B1 (de)
JP (1) JPH06510427A (de)
AT (2) ATE262584T1 (de)
AU (1) AU675410B2 (de)
CA (1) CA2115151C (de)
DE (2) DE69232121T2 (de)
DK (2) DK0667898T3 (de)
ES (2) ES2165358T3 (de)
WO (1) WO1993003148A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011231A1 (en) 1991-12-06 1993-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Tools for the diagnosis and treatment of alzheimer's disease
US7408027B1 (en) 1991-12-06 2008-08-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften Tools for the diagnosis and treatment of Alzheimer's disease
EP0646129A4 (de) * 1992-05-11 1995-07-19 Ludwig Inst Cancer Res Moleküle, welche ähnlich zur tyrosin kinase des rezeptor typs sind(13.01.94).
US6013646A (en) 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
BR0112259A (pt) * 2000-07-07 2004-03-30 Milliken & Co Substratos têxteis com melhor repelência à água e liberação de sujeira duráveis e método para produzir os mesmos
JP5186212B2 (ja) 2004-09-23 2013-04-17 ウィスタ ラボラトリーズ リミテッド メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法
ES2600915T3 (es) * 2011-10-07 2017-02-13 Ac Immune S.A. Anticuerpos fosfoespecíficos que reconocen Tau

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643235B2 (en) * 1989-09-15 1993-11-11 Gensia Pharmaceuticals, Inc. Methods of treating neurodegenerative conditions
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
WO1993003177A1 (en) * 1991-08-09 1993-02-18 Massachusetts Institute Of Technology Novel tau/neurofilament protein kinases
EP0544942A1 (de) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit

Also Published As

Publication number Publication date
DE69232121D1 (de) 2001-11-15
DK0667898T3 (da) 2002-02-04
ES2216745T3 (es) 2004-11-01
AU675410B2 (en) 1997-02-06
CA2115151A1 (en) 1993-02-18
EP1026237A2 (de) 2000-08-09
DE69233330D1 (de) 2004-04-29
EP0667898A1 (de) 1995-08-23
ES2165358T3 (es) 2002-03-16
WO1993003148A3 (en) 1993-04-01
EP0667898B1 (de) 2001-10-10
DE69232121T2 (de) 2002-06-20
AU2324092A (en) 1993-03-02
ATE262584T1 (de) 2004-04-15
EP1026237A3 (de) 2001-03-28
JPH06510427A (ja) 1994-11-24
DK1026237T3 (da) 2004-07-19
EP1026237B1 (de) 2004-03-24
DE69233330T2 (de) 2005-03-10
CA2115151C (en) 2005-05-17
WO1993003148A2 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
IE892272L (en) Novel fused heterocyclic compounds
ATE299145T1 (de) Neues multimerisierendes reagenz
NO158499C (no) Hydraulisk sementoppslemming.
NO165673C (no) Hydraulisk sementoppslemming.
EP1903112A3 (de) Activin-Rezeptoren-ähnliche Kinase, die zur TGF-Rezeptor-Familie und/oder zur BMP-Rezeptor-Familie gehört
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
ATE231505T1 (de) Neue heterocyclische/cyclische amine
NO874653D0 (no) Hydraulisk sementoppslemming.
DE69014213D1 (de) Bit-Planmodifikation.
DE69214220D1 (de) Organophiler Ton
FI853220A7 (fi) Aminoalkoksibentsopyranonit antipsykoottisina ja anksiolyyttisinä aineina.
DE68910851D1 (de) Verstärkung von optischen Signalen.
DE3872558D1 (de) Duennschichtreaktoren zur umsetzung von methan.
ATE110074T1 (de) Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
DE69200399D1 (de) Reinigung von 6-Aminocapronitril.
DE69232121D1 (de) Verwendungen einer proteinkinase von ton und neurofilament pk40
DE3853473D1 (de) Magnetische brückenanordnungen.
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
DE3768040D1 (de) Geraet zur reproduktion von dokumenten.
EP0617335A3 (de) Direktes Aufzeichnungsverfahren.
DE58909276D1 (de) Verfahren zur Übertragung von Farbstoffen.
DE69004417D1 (de) Oral verabreichte porphyrine zur regelung der eisenabsorption.
DE68905075D1 (de) Herstellung von tris(2-zyanaethyl)amin.
DK51690D0 (da) Specifikke, molekylaere dna-prober for maskulint genom af bos-typen
FR2711999B1 (fr) Pont démontable pour des besoins civils ou militaires.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee